Literature DB >> 9632358

Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.

J Alfaro-Lopez1, W Yuan, B C Phan, J Kamath, Q Lou, K S Lam, V J Hruby.   

Abstract

On the basis of the efficient substrate for p60c-src protein tyrosine kinase (PTK) YIYGSFK-NH2 (1) (Km = 55 microM) obtained by combinatorial methods, we have designed and synthesized a series of conformationally and topographically constrained substrate-based peptide inhibitors of this enzyme, which showed IC50 values in the low-micromolar range (1-3 microM). A "rotamer scan" was performed by introducing the four stereoisomers of beta-Me(2')Nal in the postulated interaction site of the peptide inhibitor 23(IC50 = 1.6 microM). This substitution led to selective and potent inhibitors of p60c-src PTK; however, no substantial difference in potency was observed among them. This and the results of the "stereochemical scan" performed at residues 2 and 7 of 3 (peptides 19-21), which form the disulfide bond, may suggest that the enzyme active site does not have rigid topographic requirements and thus is able to achieve important conformational changes to bind the ligand as long as the pharmacophore pattern in the inhibitor is conserved. Two new potent iodo-containing nonphosphorylatable tyrosine analogues were also incorporated into our lead inhibitory sequence 23, producing the most potent inhibitors for p60c-src PTK identified thus far in our studies. Compounds 29 and 30 exhibit IC50 values of 0.13 and 0.54 microM, respectively. Peptide 29 is 420-fold more potent than the parent peptide 1. Selectivity studies of peptides 23-30 toward p60c-src, Lyn, and Lck PTK showed in general high Lyn/Src and moderate Lck/Src selectivity ratios. We found that the chi1 space constraints of the specialized amino acids, introduced at position 3 of the peptide lead 23, were not as important as the configuration of the Calpha of that residue to recognize the subtle chemical environment surrounding the active site of Src and Lck PTK, as reflected on the obtained Lck/Src selectivity ratios.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632358     DOI: 10.1021/jm9707885

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.

Authors:  Anil Kumar; Guofeng Ye; Yuehao Wang; Xiaofeng Lin; Gongqin Sun; Keykavous Parang
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  Acquisition of a "Group A"-selective Src kinase inhibitor via a global targeting strategy.

Authors:  Jung-Mi Hah; Vyas Sharma; Haishan Li; David S Lawrence
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

Review 3.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

4.  Regulation of adipocyte differentiation by distinct subcellular pools of protein kinase B (PKB/Akt).

Authors:  Tamara Maiuri; Jason Ho; Vuk Stambolic
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

5.  Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries.

Authors:  Bucong Han; Xiaohua Ma; Ruiying Zhao; Jingxian Zhang; Xiaona Wei; Xianghui Liu; Xin Liu; Cunlong Zhang; Chunyan Tan; Yuyang Jiang; Yuzong Chen
Journal:  Chem Cent J       Date:  2012-11-23       Impact factor: 4.215

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.